Switch to:

Castle Biosciences Change In Receivables

: $-2.18 Mil (TTM As of Jun. 2020)
View and export this data going back to 2019. Start your Free Trial

Castle Biosciences's change in receivables for the quarter that ended in Jun. 2020 was $2.18 Mil. It means Castle Biosciences's Accounts Receivable increased by $2.18 Mil from Mar. 2020 to Jun. 2020 .

Castle Biosciences's change in receivables for the fiscal year that ended in Dec. 2019 was $-0.90 Mil. It means Castle Biosciences's Accounts Receivable declined by $0.90 Mil from Dec. 2018 to Dec. 2019 .

Castle Biosciences's Accounts Receivable for the quarter that ended in Jun. 2020 was $12.53 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Castle Biosciences's Days Sales Outstanding for the three months ended in Jun. 2020 was 89.91.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Castle Biosciences's liquidation value for the three months ended in Jun. 2020 was $146.06 Mil.


Castle Biosciences Change In Receivables Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Castle Biosciences Annual Data
Dec17 Dec18 Dec19
Change In Receivables -0.43 -8.41 -0.90

Castle Biosciences Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Change In Receivables Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.22 -2.82 -1.70 0.16 2.18

Castle Biosciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2020 was -2.824 (Sep. 2019 ) + -1.697 (Dec. 2019 ) + 0.161 (Mar. 2020 ) + 2.176 (Jun. 2020 ) = $-2.18 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Castle Biosciences  (NAS:CSTL) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Castle Biosciences's Days Sales Outstanding for the quarter that ended in Jun. 2020 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=12.528/12.715*91
=89.91

2. In Ben Graham's calculation of liquidation value, Castle Biosciences's accounts receivable are only considered to be worth 75% of book value:

Castle Biosciences's liquidation value for the quarter that ended in Jun. 2020 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=179.759-43.924+0.75 * 12.528+0.5 * 1.667
=146.06

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Castle Biosciences Change In Receivables Related Terms


Castle Biosciences Change In Receivables Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)